RMD Q2 2018 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena

RMDResMed Inc.

$35B

Q2 2018 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$601M+13.4% YoY

Gross Profit

$350M58.2% margin

Operating Income

$146M24.3% margin

Net Income

$10M1.6% margin

EPS (Diluted)

$0.07

QoQ Revenue Growth

+14.8%

Cash Flow

Operating Cash Flow

$133M

Free Cash Flow

$114M

Stock-Based Comp.

$12M

Balance Sheet

Total Assets

$3.6B

Total Liabilities

$1.5B

Stockholders' Equity

$2.0B

Cash & Equivalents

$859M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$601M	$530M	+13.4%
Gross Profit	$350M	$309M	+13.2%
Operating Income	$146M	$97M	+50.7%
Net Income	$10M	$77M	-87.6%